DZ2560A1 - Préparations pharmaceutiques de cilansétrone stabilisées contre la racémisation. - Google Patents

Préparations pharmaceutiques de cilansétrone stabilisées contre la racémisation.

Info

Publication number
DZ2560A1
DZ2560A1 DZ980170A DZ980170A DZ2560A1 DZ 2560 A1 DZ2560 A1 DZ 2560A1 DZ 980170 A DZ980170 A DZ 980170A DZ 980170 A DZ980170 A DZ 980170A DZ 2560 A1 DZ2560 A1 DZ 2560A1
Authority
DZ
Algeria
Prior art keywords
cilansetrone
pharmaceutical preparations
stabilized against
against racemization
racemization
Prior art date
Application number
DZ980170A
Other languages
English (en)
French (fr)
Inventor
Ingo Bonnacker
Hartmut Kohn
Gerhard Kristen
Christine Reichel
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of DZ2560A1 publication Critical patent/DZ2560A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DZ980170A 1997-08-01 1998-07-15 Préparations pharmaceutiques de cilansétrone stabilisées contre la racémisation. DZ2560A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19733271 1997-08-01
DE19813661A DE19813661A1 (de) 1997-08-01 1998-03-27 Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron

Publications (1)

Publication Number Publication Date
DZ2560A1 true DZ2560A1 (fr) 2003-02-15

Family

ID=7837672

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980170A DZ2560A1 (fr) 1997-08-01 1998-07-15 Préparations pharmaceutiques de cilansétrone stabilisées contre la racémisation.

Country Status (29)

Country Link
US (1) US5977127A (zh)
EP (1) EP0895782B1 (zh)
JP (1) JP4324260B2 (zh)
KR (1) KR100515201B1 (zh)
CN (1) CN1117565C (zh)
AR (1) AR010178A1 (zh)
AT (1) ATE283706T1 (zh)
AU (1) AU743043B2 (zh)
BR (1) BR9803730A (zh)
CA (1) CA2244389C (zh)
CZ (1) CZ295072B6 (zh)
DE (2) DE19813661A1 (zh)
DK (1) DK0895782T3 (zh)
DZ (1) DZ2560A1 (zh)
ES (1) ES2234051T3 (zh)
HK (1) HK1017611A1 (zh)
HU (1) HUP9801712A3 (zh)
ID (1) ID20685A (zh)
IL (1) IL125403A (zh)
NO (1) NO323229B1 (zh)
NZ (1) NZ331083A (zh)
PL (1) PL191767B1 (zh)
PT (1) PT895782E (zh)
RU (1) RU2199318C2 (zh)
SK (1) SK284916B6 (zh)
TR (1) TR199801432A3 (zh)
TW (1) TW509570B (zh)
UA (1) UA62924C2 (zh)
ZA (1) ZA986715B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
EP1372611B1 (en) * 2001-03-26 2006-05-17 Novartis AG Pharmaceutical composition comprising a poorly water-soluble staurosporine, a surfactant and a water-soluble polymer
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
JP2006516977A (ja) * 2003-01-13 2006-07-13 ダイノゲン ファーマシューティカルズ，インコーポレイテッド 悪心、嘔吐、レッチング、またはそれらの任意の組み合わせの治療方法
NZ541008A (en) * 2003-01-13 2007-09-28 Dynogen Pharmaceuticals Inc Method of treating functional bowel disorders
DE602004007225T2 (de) * 2003-04-04 2008-03-06 Dynogen Pharmaceuticals Inc., Waltham Methode zur behandlung von erkrankungen der unteren harnwege
US7820690B2 (en) * 2004-03-19 2010-10-26 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist
WO2006105117A2 (en) * 2005-03-28 2006-10-05 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
CN102186474A (zh) * 2008-08-14 2011-09-14 杏林制药株式会社 稳定的医药组合物
EP4062973A4 (en) 2019-11-20 2023-11-29 Shionogi & Co., Ltd SOLID FORMULATION CONTAINING 6,7-UNSATURATED-7-CARBAMOYL MORPHINAND DERIVATIVE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297651B1 (en) * 1987-06-29 1993-11-03 Duphar International Research B.V Anellated indole derivatives
DE4238553A1 (de) * 1992-11-14 1994-05-19 Kali Chemie Pharma Gmbh Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds

Also Published As

Publication number Publication date
EP0895782A3 (de) 2001-01-31
AR010178A1 (es) 2000-05-17
ZA986715B (en) 1999-02-04
HUP9801712A2 (hu) 1999-04-28
HK1017611A1 (en) 1999-11-26
CN1117565C (zh) 2003-08-13
EP0895782B1 (de) 2004-12-01
HUP9801712A3 (en) 2001-08-28
PL327786A1 (en) 1999-02-15
ATE283706T1 (de) 2004-12-15
CZ236798A3 (cs) 1999-02-17
KR100515201B1 (ko) 2005-12-09
AU743043B2 (en) 2002-01-17
IL125403A0 (en) 1999-03-12
CA2244389C (en) 2008-01-15
PT895782E (pt) 2005-02-28
NO983540D0 (no) 1998-07-31
NO323229B1 (no) 2007-02-05
NZ331083A (en) 2000-01-28
CN1207292A (zh) 1999-02-10
HU9801712D0 (en) 1998-09-28
IL125403A (en) 2001-11-25
US5977127A (en) 1999-11-02
AU7863098A (en) 1999-02-11
SK284916B6 (sk) 2006-02-02
EP0895782A2 (de) 1999-02-10
JP4324260B2 (ja) 2009-09-02
DK0895782T3 (da) 2005-01-03
CA2244389A1 (en) 1999-02-01
ID20685A (id) 1999-02-18
TR199801432A2 (xx) 1999-02-22
SK100998A3 (en) 1999-02-11
NO983540L (no) 1999-02-02
CZ295072B6 (cs) 2005-05-18
RU2199318C2 (ru) 2003-02-27
DE59812317D1 (de) 2005-01-05
PL191767B1 (pl) 2006-06-30
TR199801432A3 (tr) 1999-02-22
JPH1192369A (ja) 1999-04-06
TW509570B (en) 2002-11-11
DE19813661A1 (de) 1999-02-04
BR9803730A (pt) 2000-03-28
ES2234051T3 (es) 2005-06-16
KR19990023194A (ko) 1999-03-25
UA62924C2 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
DE69830095D1 (de) Pharmazeutischer, kosmetischer oder dermo-pharmazeutischer Patch zur Verabreichung mehrerer verschiedenartiger Aktivstoffe
AU5440901A (en) Cosmetic and/or pharmaceutical preparations
DK0981375T3 (da) Farmaceutiske præparater indeholdende plasmaprotein
ID19343A (id) Alat penghirup bubuk obat
NO20020304L (no) Konserverte farmasoytiske preparater
EG26803A (en) Fixed pharmaceuticals of gabainetin or pregabalin with amino acid
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
ID24654A (id) Formulasi farmasi omeprazola
ATE367150T1 (de) Arzneimittel
NO974618D0 (no) Farmasöytiske preparater for intranasal administrasjon
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
DK0780369T3 (da) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-forbindelser som farmaceutisk virksomme stoffer
ATE238812T1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
ATE266383T1 (de) Dermatologische zubereitungen
NO20000231D0 (no) Dolastatin-15-derivater
PT1071433E (pt) 2',2'-difluoronuecleosidos para terapia imunossupressora e preparados farmaceuticos combinados
NO20006646L (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
DZ2560A1 (fr) Préparations pharmaceutiques de cilansétrone stabilisées contre la racémisation.
HUP9903353A3 (en) 7alpha-(methyl-amino-pentyl)-estratrienes, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl) -estratrienes and use thereof for production of drugs
DZ1926A1 (fr) Formulations pharmaceutiques.
AU2438400A (en) Cosmetic and/or pharmaceutical preparations
DE69926012D1 (de) Arzneizubereitungen